v3.26.1
Stock Options and Restricted Stock - Summary of Activity for Performance Stock Units and Restricted Stock Programs (Detail) - $ / shares
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2026
Mar. 31, 2026
Jun. 30, 2026
Dec. 31, 2025
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares, vested     (414,648)  
Grant price per share, cancelled, lower limit [1]       $ 4.89
Grant price per share, cancelled, upper limit $ 0 $ 0   $ 6.79 [1]
PSU [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares, beginning balance 744,350 823,854 823,854 512,131
Number of shares, granted 0 216,940   311,723
Number of shares, cancelled (67,788) 0   0
Number of shares, vested 0 [2] (296,444) [2]   0
Number of shares, ending balance 676,562 744,350 676,562 823,854
Grant price per share, lower range limit beginning balance $ 8.47 $ 6.08 $ 6.08 $ 6.08
Grant price per share, upper range limit beginning balance 10.36 8.97 8.97 8.97
Grant price per share, granted, upper limit 0 10.34   8.47
Grant price per share, cancelled, lower limit 8.47      
Grant price per share, cancelled, upper limit 8.97 0   0
Grant price per share, vested, upper limit 0 [2] 6.08 [2]   0
Grant price per share, lower range limit ending balance 8.47 8.47 8.47 6.08
Grant price per share, upper range limit ending balance 10.36 10.36 10.36 8.97
Weighted average grant price beginning balance 9.17 7.74 7.74 7.3
Weighted average grant price, granted 0 10.34   8.47
Weighted average grant price, cancelled 8.71 0   0
Weighted average grant price, vested 0 [2] 6.08 [2]   0
Weighted average grant price, ending balance $ 9.21 $ 9.17 $ 9.21 $ 7.74
Restricted Shares [Member]        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Number of shares, beginning balance 719,590 [3] 751,750 751,750 909,028
Number of shares, granted 0 344,206   332,918
Number of shares, cancelled (33,140) (1,569)   (5,373)
Number of shares, vested [4] (92,978) (374,797)   (484,823)
Number of shares, ending balance 593,472 [3] 719,590 [3] 593,472 [3] 751,750
Grant price per share, lower range limit beginning balance $ 8.47 $ 8.08 $ 8.08 $ 4.89
Grant price per share, upper range limit beginning balance 10.57 10.57 10.57 10.32
Grant price per share, granted, lower limit       8.47
Grant price per share, granted, upper limit 0 10.36   10.57
Grant price per share, cancelled, lower limit 8.47 9.37   4.89
Grant price per share, cancelled, upper limit 10.57 10.32   10.32
Grant price per share, vested, lower limit [4] 8.47 8.08   4.89
Grant price per share, vested, upper limit [4] 10.36 9.37   8.97
Grant price per share, lower range limit ending balance 8.47 [3] 8.47 8.47 [3] 8.08
Grant price per share, upper range limit ending balance 10.57 [3] 10.57 10.57 [3] 10.57
Weighted average grant price beginning balance 9.64 [3] 8.83 8.83 8.3
Weighted average grant price, granted 0 10.36   8.63
Weighted average grant price, cancelled 0 9.82   9.16
Weighted average grant price, vested [4] 0 8.67   7.7
Weighted average grant price, ending balance $ 8.77 [3] $ 9.64 [3] $ 8.77 [3] $ 8.83
[1] The intrinsic value of the options vested was $0.1 million for the year ended December 31, 2025.
[2] During the three and six months ended June 30, 2026, 0 and 652,577 shares were used in connection with the vesting and settlement of PSUs.
[3] The aggregate fair value of the unvested restricted stock was $6.1 million as of June 30, 2026. The remaining vesting period was 2.7 years at June 30, 2026.
[4] The aggregate fair value of the restricted stock vested, on the date of vesting, was $0.9 million and $4.7 million for the three and six months ended June 30, 2026 and $4.2 million for the year ended December 31, 2025